These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8923286)
1. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein. Ferns RB; Tuke PW; Sweenie CH J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486 [TBL] [Abstract][Full Text] [Related]
3. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. Moradpour D; Wakita T; Tokushige K; Carlson RI; Krawczynski K; Wands JR J Med Virol; 1996 Mar; 48(3):234-41. PubMed ID: 8801283 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus core protein fused to hepatitis B virus core antigen for serological diagnosis of both hepatitis C and hepatitis B infections by ELISA. Wu CL; Leu TS; Chang TT; Shiau AL J Med Virol; 1999 Feb; 57(2):104-10. PubMed ID: 9892392 [TBL] [Abstract][Full Text] [Related]
5. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein. Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468 [TBL] [Abstract][Full Text] [Related]
6. Characterization of antigenic determinants in the core antigen of the hepatitis C virus. Goeser T; Müller HM; Ye J; Pfaff E; Theilmann L Virology; 1994 Dec; 205(2):462-9. PubMed ID: 7526540 [TBL] [Abstract][Full Text] [Related]
7. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen. León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151 [TBL] [Abstract][Full Text] [Related]
8. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020 [TBL] [Abstract][Full Text] [Related]
9. Antigenic relevance of F protein in chronic hepatitis C virus infection. Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
11. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice. Hitomi Y; McDonnell WM; Baker JR; Askari FK Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296 [TBL] [Abstract][Full Text] [Related]
12. Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity. Mihailova M; Fiedler M; Boos M; Petrovskis I; Sominskaya I; Roggendorf M; Viazov S; Pumpens P Protein Expr Purif; 2006 Nov; 50(1):43-8. PubMed ID: 16889980 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of anti-HCV antibody and HCV core antigen. Ansaldi F; Icardi G Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250 [TBL] [Abstract][Full Text] [Related]
14. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays. Ali A; Nisar M; Idrees M; Rafique S; Iqbal M Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431 [TBL] [Abstract][Full Text] [Related]
15. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains. Andersson HA; Singh RA; Barry MA Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998 [TBL] [Abstract][Full Text] [Related]
16. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977 [TBL] [Abstract][Full Text] [Related]
17. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products. Ansari MA; Irshad M; Agarwal SK; Chosdol K Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416 [TBL] [Abstract][Full Text] [Related]
18. B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Akatsuka T; Donets M; Scaglione L; Ching WM; Shih JW; Di Bisceglie AM; Feinstone SM Hepatology; 1993 Sep; 18(3):503-10. PubMed ID: 7689529 [TBL] [Abstract][Full Text] [Related]
19. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies. Cerino A; Mondelli MU J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573 [TBL] [Abstract][Full Text] [Related]
20. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies. Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]